Multipotent Hepatoprotector Larnamin in Clinical Practice
Journal Title: Гастроентерологія - Year 2016, Vol 1, Issue 59
Abstract
The article presents a literature review on the physiological mechanisms of action and evidence base of L-ornithine-L-aspartate — an active substance of the drug Larnamin. Multifaceted properties of the drug are shown: detoxification, anabolic, hepatoprotective, vasodilating ones, the ability to stimulate the production of growth hormone and insulin. The results of clinical studies proving the effectiveness of L-ornithine-L-aspartate in hepatic encephalopathy, chronic diffuse liver diseases, including alcoholic and nonalcoholic fatty liver disease, are described. The drug is also effective in acute pancreatitis, alcoholic intoxication. Drug tolerance is satisfactory, the likelihood and severity of side effects are minimal.
Authors and Affiliations
N. B. Huberhrits, O. Ye. Klochkov, P. H. Fomenko, N. V. Bieliaieva
Keywords
Related Articles
- EP ID EP209605
- DOI -
- Views 107
- Downloads 0
Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
The results of the research suggest the same therapeutic efficacy of oral and intravenous forms of omeprazole in patients with peptic ulcer bleeding. This formulation should be administered at a high dose (orally first d...
Peculiarities and Possible Correction of Intestinal Dysbiosis in Patients with Coronary Heart Disease
Article presents the results of examination and treatment of 107 patients with coronary heart disease combined with intestine dysbiosis. It is shown that the dominant symptom of intestinal dysbiosis in patients with coro...
Dynamics of Clinical and Biochemical Parameters in Patients with Liver Cirrhosis Under the Influence of Complex Therapy with Ursodeoxycholic Acid
It was studied dynamics of clinical and biochemical parameters in patients with liver cirrhosis under the influence of complex treatment using ursosan. It is found that the inclusion of ursosan in complex treatment impro...
Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
The article displays current views on the process of fibrogenesis in patients with fatty liver disease. It is shown that steatosis and steatohepatitis are the main triggers of the process of fibrogenesis. Modern mechanis...
Inflammation in Chronic Hepatic Diseases and Possible Approaches to the Treatment
Inflammation reactions are the central component of liver regeneration after injury of various etiologies. The realization of these reactions involves a large number of pro-inflammatory cytokines: interferons, interleuki...